Actively Recruiting
Lorraine Registry of Multiple Sclerosis
Led by Central Hospital, Nancy, France · Updated on 2023-02-08
6000
Participants Needed
1
Research Sites
1391 weeks
Total Duration
On this page
Sponsors
C
Central Hospital, Nancy, France
Lead Sponsor
I
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
The RelSEP aims to register exhaustively every new case of multiple sclerosis (MS) occuring in Lorraine a French region, and follow up on them for an indefinite duration, registering disease evolution and intercurrent events.
CONDITIONS
Official Title
Lorraine Registry of Multiple Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Having a confirmed multiple sclerosis diagnosis
- Living in Lorraine (French region)
You will not qualify if you...
- Refusal to be registered
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CIC 1433 Épidémiologie clinique, Inserm, Université de Lorraine, CHRU de Nancy
Nancy, France, 54000
Actively Recruiting
Research Team
F
Francis Guillemin, MD, PHD
CONTACT
J
Jonathan Epstein, MD, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here